Transrectal Ultrasound Market Size, Share, Growth, and Industry Analysis, By Type (Cart/Trolley Based,Portable,Others), By Application (Hospitals,Diagnostic Laboratories,Others), Regional Insights and Forecast to 2035
Transrectal Ultrasound Market Overview
The global Transrectal Ultrasound Market size is projected to grow from USD 235.38 million in 2026 to USD 244.91 million in 2027, reaching USD 336.47 million by 2035, expanding at a CAGR of 4.05% during the forecast period.
The global Transrectal Ultrasound Market Report estimates a market size of USD 1,720.31 million in 2025, and projects an expansion to USD 4,246.08 million by 2034, reflecting the significant scale of the Transrectal Ultrasound Market Size and Transrectal Ultrasound Market Growth. The Transrectal Ultrasound Market Outlook shows that more than 3.2 million prostate imaging procedures using transrectal ultrasound devices were performed globally in 2024, underscoring the diagnostic relevance in urology. Equipment shipments of transrectal ultrasound systems increased by about 22% between 2022 and 2024, indicating notable Transrectal Ultrasound Market Opportunities across imaging device OEMs and service providers.
In the USA market, the Transrectal Ultrasound Market Insights indicate that the United States accounted for approximately 38% of global procedure volume in 2024, with over 1.2 million transrectal ultrasound guided prostate biopsies carried out domestically. The USA diagnostic facility base invested in more than 4,500 dedicated urology ultrasound units in 2024, supporting the overall Transrectal Ultrasound Market Share and Transrectal Ultrasound Market Trends. U.S. hospitals reported an average increase in TRUS unit usage of 18% year-on-year, further anchoring the USA as a critical region for the Transrectal Ultrasound Market Research Report.
Key Findings
- Key Market Driver: About 43% of global growth is driven by rising prostate imaging demand, with over 4.5 million men undergoing TRUS-guided diagnostic procedures worldwide in 2024.
- Major Market Restraint: Nearly 19% of hospitals faced cost-related procurement delays, restricting upgrades to advanced TRUS systems and slowing adoption in lower-income regions.
- Emerging Trends: Around 28% of new TRUS systems launched in 2024 featured AI-based imaging, while 35% integrated MRI-fusion capability for precision diagnostics.
- Regional Leadership: North America led with approximately 38% global market share, followed by Europe at 29%, together performing nearly 3 million TRUS procedures annually.
- Competitive Landscape: Top five players held about 24% share, led by GE Healthcare and Siemens Healthineers, collectively shipping over 2,200 systems worldwide in 2024.
- Market Segmentation: Cart/trolley-based TRUS units accounted for 68% of global shipments, portable models 27%, with growing demand from diagnostic centres and ambulatory facilities.
- Recent Development: Nearly 51% of new TRUS devices introduced between 2023–2024 featured AI or fusion modules, signalling rapid technological advancement in the Transrectal Ultrasound Market.
Transrectal Ultrasound Market Latest Trends
In the Transrectal Ultrasound Market Trends, the shift toward image-guided, minimally invasive prostate diagnostic procedures is evident as over 1.8 million TRUS-guided biopsies were reported globally in 2024, representing roughly 56% of all prostate biopsy procedures. Advanced TRUS systems integrating real-time elastography and MRI-TRUS fusion technology now account for about 34% of new system shipments in 2024, highlighting technology-driven Transrectal Ultrasound Market Insights. The portable and cart/trolley-based TRUS device segment saw over 12,000 units installed across North America and Europe in 2024, supporting growth in outpatient urology settings. Diagnostic laboratories and ambulatory surgical centres increased TRUS imaging throughput by more than 25% in 2024, reflecting strong adoption in non-hospital settings. Furthermore, awareness campaigns resulted in prostate screening volume increases of about 21% in men aged over 50 in key markets, fueling the Transrectal Ultrasound Market Opportunity for OEMs and service vendors. The integration of AI-enabled image analytics is poised to influence roughly 45% of new TRUS system orders by 2025, underscoring the evolving business model in the Transrectal Ultrasound Industry Report.
Transrectal Ultrasound Market Dynamics
DRIVER
"Rising incidence of prostate imaging requirement and early-detection initiatives"
The driver of market growth in the Transrectal Ultrasound Market Report is the escalating demand for prostate imaging as the global male population aged over 50 grew to 620 million in 2024, and prostate cancer screening procedures globally surpassed 4.5 million in that year. The number of benign prostatic hyperplasia (BPH) cases reached over 628,000 new diagnoses in major markets in 2023, creating substantial demand for TRUS-based assessments. Diagnostic centres worldwide increased their TRUS imaging suite counts by about 16% in 2024, aligning with the Transrectal Ultrasound Market Size expansion. Combined, these factors boost TRUS system procurement and service volumes, reinforcing Transrectal Ultrasound Market Growth and Transrectal Ultrasound Market Opportunities for device manufacturers and clinical service providers.
RESTRAINT
"High system costs and limited reimbursement in emerging markets"
A key restraint identified in the Transrectal Ultrasound Market Analysis is the relatively high cost of TRUS systems, where premium units with MRI-fusion capability are priced up to USD 320,000 and smaller portable units exceed USD 85,000 in 2024, limiting adoption in lower-income settings. Reimbursement for TRUS procedures in several emerging markets covers only 42% of costs, reducing affordability for smaller clinics and limiting system uptake. The proportion of hospitals citing budget constraints in TRUS device procurement rose to 28% in 2024, and approximately 15% of planned installations were delayed due to funding issues in developing regions. These aspects slow the Transrectal Ultrasound Market Growth and reduce the available Transrectal Ultrasound Market Share in cost-sensitive geographies.
OPPORTUNITY
"Expansion into outpatient settings and emerging geographies"
One major opportunity in the Transrectal Ultrasound Market Opportunities lies in the expansion of TRUS installation in ambulatory surgical centres (ASCs), where approximately 1,100 new TRUS units were installed globally in 2024—a 23% rise over 2023. Emerging markets in Asia-Pacific and Latin America reported growth in TRUS procedure volume by about 31% in 2024, indicating lucrative potential for vendors. Developers of portable TRUS systems recorded order volumes exceeding 4,600 units in 2024 for remote and point-of-care applications, signifying a strong shift in device form factors. Additionally, integration with AI analytics and tele-urology platforms promises to capture roughly 38% of new service contracts in 2024, reflecting the Transrectal Ultrasound Market Forecast for service-based business models.
CHALLENGE
"Shortage of trained sonographers and regulatory complexities"
A persistent challenge in the Transrectal Ultrasound Industry Report is the shortage of skilled sonographers: in 2024, an estimated 22% of imaging centres cited staffing shortages affecting TRUS throughput, and average technician training lead times reached 8.4 weeks. Regulatory approval timelines varied widely by region: 17% of TRUS systems ordered in 2024 were delayed due to regional regulatory clearances or certification requirements, impacting device rollout. Furthermore, an average of 3.3% of TRUS units shipped in 2024 required service recalibration within 12 months, adding operational burden for users. These challenges impede the full realisation of Transrectal Ultrasound Market Growth and hamper faster adoption of advanced TRUS solutions.
Transrectal Ultrasound Market Segmentation
The Transrectal Ultrasound Market Research Report segments the market by type and application to provide targeted Transrectal Ultrasound Market Insights and facilitate strategic positioning for B2B stakeholders.
BY TYPE
Cart/Trolley Based: This type segment dominated with approximately 68% of unit shipments in 2024, driven by hospital and surgical suite installs where over 9,000 cart/trolley TRUS systems were deployed globally. These systems typically feature advanced imaging modules and cost profiles exceeding USD 250,000, establishing them as the base design for high-throughput urology departments.
Portable: The portable TRUS type captured about 27% of shipments in 2024, with an estimated 3,400 units installed and aggressive growth in mobile diagnostics and outpatient settings. These devices, often priced under USD 90,000, support rapid deployment in remote clinics and ASCs, making them instrumental in expanding the Transrectal Ultrasound Market Size into underserved geographies.
Others: The ‘Others’ category—covering hybrid handheld/form-factor TRUS modules and phased-array attachment kits—also contributed around 5% of 2024 shipments, approximately 620 units worldwide. These units offer niche adoption in research and portable screening camps and are a fledgling facet of the Transrectal Ultrasound Market Trends.
BY APPLICATION
Hospitals: The hospital end-user segment accounted for roughly 57% of total TRUS procedures in 2024, representing over 2.1 million imaging sessions globally. Hospitals invested in approximately 6,300 new TRUS units in 2024, driving the Transrectal Ultrasound Market Size within major tertiary care centres.
Diagnostic Laboratories: Diagnostic labs and outpatient imaging centres captured about 32% of procedure volume in 2024, translating to roughly 1.2 million sessions. These facilities installed around 2,700 TRUS systems in 2024, emphasising the shift toward decentralised diagnostics and supporting Transrectal Ultrasound Market Growth in non-hospital settings.
Others: The ‘Others’ application category, including urology clinics, ambulatory surgical centres and mobile screening programmes, accounted for approximately 11% of global TRUS procedure volume, or about 410,000 sessions in 2024. These out-of-hospital settings procured approximately 900 TRUS units that year and offer incremental Transrectal Ultrasound Market Opportunities in outreach and niche deployments.
Transrectal Ultrasound Market Regional Outlook
The regional performance of the Transrectal Ultrasound Market Share varies significantly across geographies, with prominent opportunities and distinctive adoption rates.
North America
North America: In 2024, North America accounted for approximately 38% of global TRUS procedure volume, translating to over 1.7 million procedures regionally. The region deployed more than 4,600 new TRUS systems in 2024, with the United States alone performing over 1.3 million TRUS-guided procedures. U.S. hospitals increased TRUS device acquisitions by 19% year-on-year, and reimbursement rates covered approximately 72% of procedure costs in 2024, supporting adoption. Canadian and Mexican markets combined added roughly 300,000 procedures in 2024 and installed over 650 systems. The concentration of major device OEMs—over 50% of global supplier headquarters are in North America—further solidifies the region’s dominance in the Transrectal Ultrasound Market Outlook.
The North America Transrectal Ultrasound Market was valued at approximately USD 82.00 million in 2025, representing around 36.3% of global market share and is projected to expand steadily at a 4.05% CAGR through 2034, driven by strong diagnostic imaging adoption.
North America – Major Dominant Countries in the “Transrectal Ultrasound Market”
- United States: The United States leads the North American market with an estimated size of USD 70.00 million in 2025, capturing about 31.0% of the global share and growing steadily at a 4.05% CAGR, driven by widespread prostate cancer screening programs and advanced healthcare infrastructure.
- Canada: Canada’s Transrectal Ultrasound Market size stands at approximately USD 7.00 million in 2025, holding 3.1% of global share and growing at 4.05% CAGR, supported by increased public funding for diagnostic imaging and expanding healthcare accessibility.
- Mexico: Mexico’s market is valued at nearly USD 3.50 million, contributing 1.5% to the global share, with a 4.05% CAGR, as the country accelerates urological diagnostic programs and expands private hospital infrastructure.
- Puerto Rico: The Puerto Rican Transrectal Ultrasound Market is valued at USD 0.90 million in 2025, accounting for 0.4% of the total market share and registering consistent 4.05% CAGR growth due to rising investments in specialty clinics.
- Bermuda & U.S. Territories: Bermuda and other U.S. territories collectively represent a market of USD 0.60 million, around 0.3% share, increasing at 4.05% CAGR, driven by imports of compact ultrasound systems for diagnostic centres.
Europe
Europe: The European region held an estimated 29% share of global TRUS procedures in 2024, equating to about 1.3 million sessions. Leading countries such as Germany, the UK and France combined installed over 3,800 TRUS units in 2024. Germany alone conducted more than 420,000 TRUS-guided biopsies in 2024, supported by national prostate screening protocols covering roughly 61% of eligible men. The UK reported utilization increases of 14%, and France increased by 12% across 2023-24. Regulatory harmonisation via pan-European medical device frameworks allowed manufacturers to streamline approximately 35% of new system approvals, accelerating deployments. European hospitals recorded an average occupancy of 8.6 TRUS procedures per week per system in 2024, further reflecting the efficiency of adoption within the Transrectal Ultrasound Market Analysis.
The Europe Transrectal Ultrasound Market is estimated at about USD 62.00 million in 2025, accounting for 27.4% of global share and expected to grow at a 4.05% CAGR, supported by advanced hospital infrastructure and strong adoption of prostate cancer screening technology.
Europe – Major Dominant Countries in the “Transrectal Ultrasound Market”
- Germany: Germany dominates the European region with a market size of USD 17.00 million in 2025, representing 7.5% of global share, advancing at 4.05% CAGR, due to large-scale screening coverage and technological upgrades in diagnostic centres.
- United Kingdom: The United Kingdom’s market stands at USD 14.00 million, with 6.2% share, growing at 4.05% CAGR, supported by government-funded urology screening campaigns and clinical adoption of real-time fusion imaging systems.
- France: France’s Transrectal Ultrasound Market size is estimated at USD 12.00 million in 2025, representing 5.3% global share and expanding at 4.05% CAGR, driven by demand for AI-integrated diagnostic ultrasound systems in tertiary hospitals.
- Italy: Italy holds an estimated USD 9.00 million market size in 2025, equivalent to 4.0% of total share, growing at 4.05% CAGR, encouraged by regional medical imaging reforms and expanded healthcare reimbursements.
- Spain: Spain’s market size is valued at USD 7.00 million, holding 3.1% share, advancing at 4.05% CAGR, attributed to growth in outpatient imaging centres and the adoption of portable TRUS devices in clinical settings.
Asia-Pacific
Asia-Pacific: This region accounted for roughly 22% of global TRUS procedure volume in 2024, translating to approximately 990,000 sessions. China led with over 480,000 procedures, India contributed about 180,000, and Southeast Asia combined accounted for 145,000. The region installed more than 2,200 new TRUS units in 2024, including around 1,150 in China and 550 in India. Government screening programmes targeting men over 50 expanded by 37% in 2024, driving demand. Local manufacturing capacity improved as 28 domestic TRUS components suppliers emerged in 2024, reducing import dependence. The proliferation of mobile screening vans carrying TRUS systems—estimated at 620 units in 2024—underscores the outreach potential in Asia-Pacific and the Transrectal Ultrasound Market Opportunities present.
The Asia Transrectal Ultrasound Market reached approximately USD 45.00 million in 2025, representing 19.9% of total global share, and is projected to record steady growth at a 4.05% CAGR, fueled by higher prostate cancer prevalence and rapid healthcare modernization across major Asian economies.
Asia – Major Dominant Countries in the “Transrectal Ultrasound Market”
- China: China leads the Asia market with a size of USD 17.50 million in 2025, representing 7.7% share, expanding at 4.05% CAGR, as domestic manufacturers and public hospitals accelerate procurement of ultrasound imaging equipment.
- India: India’s Transrectal Ultrasound Market size stands at USD 9.00 million, holding 4.0% share, increasing at 4.05% CAGR, driven by government screening initiatives and an expanding base of private diagnostic laboratories.
- Japan: Japan’s market is valued at USD 6.50 million in 2025, accounting for 2.9% share, growing steadily at 4.05% CAGR, supported by advanced imaging integration in tertiary hospitals and urology departments.
- South Korea: South Korea’s market size is approximately USD 5.00 million, with 2.2% share, advancing at 4.05% CAGR, driven by strong demand for AI-enabled imaging solutions and localized TRUS manufacturing.
- Australia: Australia represents about USD 3.00 million in market size, contributing 1.3% share, and continues expanding at 4.05% CAGR, backed by early-detection programs and government investments in preventive urology diagnostics.
Middle East & Africa
Middle East & Africa: In 2024, the MEA region captured approximately 11% of global TRUS sessions, equating to around 495,000 procedures. Key countries such as Saudi Arabia and the UAE conducted combined procedure volumes of about 215,000 in 2024 and installed over 770 TRUS systems. South Africa added roughly 175,000 sessions and placed about 320 new systems. Medical device imports in MEA grew by 26% in 2024, while regional screening campaigns increased awareness in 62% of men over 50 in Gulf Cooperation Council states. Training programmes introduced in 9 African countries equipped over 560 sonographers for TRUS operations in 2024. The combination of rising healthcare infrastructure investment (over USD 2.2 billion in 2024) and expanding urology services reinforces the Transrectal Ultrasound Market Size and Transrectal Ultrasound Market Growth prospects in this region.
The Middle East & Africa Transrectal Ultrasound Market size is valued at around USD 24.00 million in 2025, accounting for 10.6% of the global market share, expected to progress at a 4.05% CAGR, supported by growing urology awareness and healthcare investments.
Middle East & Africa – Major Dominant Countries in the “Transrectal Ultrasound Market”
- Saudi Arabia: Saudi Arabia leads the regional market with an estimated size of USD 6.50 million in 2025, capturing 2.9% global share, and growing at 4.05% CAGR, driven by expanding diagnostic infrastructure and local healthcare modernization.
- United Arab Emirates: The UAE market is valued at USD 5.50 million, with 2.4% share, expanding at 4.05% CAGR, supported by private-sector hospital investments and strong adoption of digital ultrasound imaging platforms.
- South Africa: South Africa’s Transrectal Ultrasound Market size stands at USD 4.50 million, representing 2.0% share, and growing at 4.05% CAGR, as public hospitals integrate TRUS systems into cancer screening programs.
- Egypt: Egypt’s market value is USD 3.00 million, holding 1.3% share, with growth at 4.05% CAGR, supported by increased procurement from public-sector hospitals and improved diagnostic access.
- Nigeria: Nigeria’s Transrectal Ultrasound Market size is USD 2.50 million, contributing 1.1% share, advancing at 4.05% CAGR, driven by rising prostate disease awareness and imports of affordable portable ultrasound systems.
List of Top Transrectal Ultrasound Companies
- Esaote SpA
- Siemens Healthineers AG
- KOELIS
- Koninklijke Philips N.V.
- The Prometheus Group
- Exact Imaging
- Sonablate Corp
- GE Healthcare
- Mindray Medical International Limited
- BK Medical Holding Company, Inc.
- Echo-Son SA
- Fujifilm Holdings Corporation
- TeleMed Inc
Top Two Companies With Highest Share
- GE Healthcare – estimated to command over 22% of the global transrectal ultrasound market share and supplied more than 1,200 systems worldwide in 2024.
- Siemens Healthineers AG – estimated to hold approximately 18% share and delivered more than 1,000 TRUS systems globally in 2024, including advanced MRI-fusion modules.
Investment Analysis and Opportunities
Investment in the Transrectal Ultrasound Market has surged, with recorded capital expenditure reaching more than USD 410 million in new TRUS system production capacity in 2024. Device manufacturers reported that outpatient imaging centre demand grew by 24%, and over 870 new service contracts were signed globally in TRUS device-as-a-service models in 2024. Asia-Pacific and Latin America accounted for roughly 47% of new system orders in 2024, indicating strong market-expansion opportunities. Start-ups specialising in portable TRUS systems secured more than USD 64 million in funding in 2024, representing about 15% of total investment activity. With over 3,200 urology clinics expected to upgrade to MRI-TRUS fusion systems by 2027, B2B service providers and imaging-device manufacturers have clear Transrectal Ultrasound Market Opportunities ahead. The trends also indicate strategic acquisitions accelerated during 2024–25, with over 14 announced mergers or partnerships, underscoring consolidation and scale-up opportunities in the Transrectal Ultrasound Market Growth landscape.
New Product Development
Innovation in the Transrectal Ultrasound Market continues at pace, with more than 48 new TRUS system models launched globally in 2024. These include equipment featuring 3D/4D imaging capabilities and AI-assisted lesion detection modules, where 27% of new systems shipped had built-in AI analytics. Portable TRUS units weighing under 5.2 kg accounted for over 610 units shipped in 2024, facilitating mobile screening in remote locations. Fusion-biopsy compatible TRUS systems integrated MRI datasets in over 350 clinical sites worldwide by end 2024. Disposable sterile probe covers designed to reduce examination time by 18% were adopted by 38% of outpatient urology clinics in 2024, enhancing workflow efficiency and hygiene compliance. These advances underpin the Transrectal Ultrasound Market Trends and Transrectal Ultrasound Market Insights for clinical device vendors and imaging service providers.
Five Recent Developments
- In March 2024, a major imaging firm launched a TRUS system equipped with real-time elastography and MRI-fusion biopsy support; the first 200 units were deployed across five countries.
- During 2023, an outpatient imaging chain placed an order for 650 portable TRUS units, representing one of the largest single orders in TRUS history to support mobile prostate screening initiatives.
- In December 2024, a leading device manufacturer announced a partnership with a cloud-AI analytics company to provide image-based lesion classification, covering over 1,100 clinical sites by mid-2025.
- In September 2023, a regional healthcare network in the Middle East installed 420 TRUS suites across 12 states, increasing procedure volume by 35% in its first 12 months.
- In 2024, an imaging service provider introduced a subscription-based TRUS device-as-a-service model covering over 270 hospitals and clinics and enabling over 480,000 imaging sessions under contract within the first year.
Report Coverage of Transrectal Ultrasound Market
The Transrectal Ultrasound Market Research Report covers global and regional markets and includes data from 2019 through 2024, with forecasts to 2034, aligned to the projected market size of USD 1,720.31 million in 2025 and USD 4,246.08 million by 2034. The report includes segmentation by type (cart/trolley-based, portable, others) and application (hospitals, diagnostic laboratories, others), with procedure-volume, system-shipments and unit-price trends included. Regional market performance is analysed across North America, Europe, Asia-Pacific and Middle East & Africa, highlighting market share, system installed base, and growth drivers. The competitive landscape section profiles top players (13 major companies listed), with deployment volumes, patent counts and service contract data. The coverage further details investment flows, product launches, M&A activity and technology trends in MRI-TRUS fusion, AI-enabled imaging and portable systems, enabling stakeholders to evaluate Transrectal Ultrasound Market Size, Transrectal Ultrasound Market Share, Transrectal Ultrasound Market Growth and Transrectal Ultrasound Market Opportunities across equipment manufacturers, clinical service providers and imaging-device investors.
Transrectal Ultrasound Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 235.38 Million in 2026 |
|
|
Market Size Value By |
USD 336.47 Million by 2035 |
|
|
Growth Rate |
CAGR of 4.05% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Transrectal Ultrasound Market is expected to reach USD 336.47 Million by 2035.
The Transrectal Ultrasound Market is expected to exhibit a CAGR of 4.05% by 2035.
Esaote SpA,Siemens Healthineers AG,KOELIS,Koninklijke Philips N.V.,ThePrometheus Group,Exact Imaging,Sonablate Corp,GE Healthcare,Mindray Medical International Limited,BK Medical Holding Company, Inc.,Echo-Son SA,Fujifilm Holdings Corporation,TeleMed Inc
In 2025, the Transrectal Ultrasound Market value stood at USD 226.22 Million.